chr19-7534849-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001166111.2(PNPLA6):​c.-96A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 153,734 control chromosomes in the GnomAD database, including 6,013 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 5965 hom., cov: 32)
Exomes 𝑓: 0.22 ( 48 hom. )

Consequence

PNPLA6
NM_001166111.2 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.105

Publications

11 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-7534849-A-C is Benign according to our data. Variant chr19-7534849-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 330509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166111.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
NM_001166111.2
c.-96A>C
5_prime_UTR
Exon 1 of 34NP_001159583.1Q8IY17-4
PNPLA6
NM_001166113.1
c.-172A>C
5_prime_UTR
Exon 1 of 35NP_001159585.1Q8IY17-2
PNPLA6
NM_006702.5
c.-96A>C
5_prime_UTR
Exon 2 of 35NP_006693.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
ENST00000221249.10
TSL:1
c.-96A>C
5_prime_UTR
Exon 2 of 35ENSP00000221249.5Q8IY17-2
PNPLA6
ENST00000450331.7
TSL:1
c.-172A>C
5_prime_UTR
Exon 1 of 35ENSP00000394348.2Q8IY17-2
ENSG00000268614
ENST00000601870.1
TSL:4
n.*318A>C
non_coding_transcript_exon
Exon 5 of 10ENSP00000471492.1M0R0W3

Frequencies

GnomAD3 genomes
AF:
0.277
AC:
42098
AN:
151914
Hom.:
5945
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.233
Gnomad AMR
AF:
0.295
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.290
Gnomad SAS
AF:
0.231
Gnomad FIN
AF:
0.308
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.240
GnomAD4 exome
AF:
0.216
AC:
367
AN:
1702
Hom.:
48
Cov.:
0
AF XY:
0.209
AC XY:
203
AN XY:
972
show subpopulations
African (AFR)
AF:
0.200
AC:
2
AN:
10
American (AMR)
AF:
0.259
AC:
85
AN:
328
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8
East Asian (EAS)
AF:
0.318
AC:
7
AN:
22
South Asian (SAS)
AF:
0.181
AC:
55
AN:
304
European-Finnish (FIN)
AF:
0.0833
AC:
1
AN:
12
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.210
AC:
202
AN:
962
Other (OTH)
AF:
0.278
AC:
15
AN:
54
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.277
AC:
42153
AN:
152032
Hom.:
5965
Cov.:
32
AF XY:
0.275
AC XY:
20430
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.285
AC:
11832
AN:
41460
American (AMR)
AF:
0.296
AC:
4524
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
579
AN:
3472
East Asian (EAS)
AF:
0.291
AC:
1501
AN:
5160
South Asian (SAS)
AF:
0.232
AC:
1120
AN:
4820
European-Finnish (FIN)
AF:
0.308
AC:
3260
AN:
10586
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18576
AN:
67942
Other (OTH)
AF:
0.240
AC:
507
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1593
3187
4780
6374
7967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
19029
Bravo
AF:
0.278
Asia WGS
AF:
0.294
AC:
1021
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Hereditary spastic paraplegia 39 (1)
-
-
1
Mucolipidosis type IV (1)
-
-
1
Spastic Paraplegia, Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.8
DANN
Benign
0.57
PhyloP100
-0.10
PromoterAI
-0.042
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs604959; hg19: chr19-7599735; API